Pharma Journalist -

GSK plc announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has accepted for review a new drug application (NDA) for Blenrep (belantamab mafodotin) in combination with…
Read More...

Novartis announced that the US Food and Drug Administration (FDA) has approved Kisqali (ribociclib) in combination with an aromatase inhibitor (AI) for the adjuvant treatment of people…
Read More...

Zentalis Pharmaceuticals, Inc. a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental…
Read More...

Sanofi is shipping BEYFORTUS (nirsevimab-alip) 50mg and 100mg Injection doses in the US to private healthcare providers and to the Centers for Disease Control and Prevention for its…
Read More...

MaxCyte, Inc.,, a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation…
Read More...

SOPHiA GENETICS, a cloud-native healthcare technology company and a global leader in data-driven medicine, announced a new milestone in the global introduction of the liquid biopsy test…
Read More...

Gilead Sciences, Inc. and Genesis Therapeutics, Inc. announced that the companies have entered into a strategic collaboration to discover and develop novel, small molecule therapies…
Read More...

Candid Therapeutics, Inc., a biotechnology company dedicated to developing potentially transformative drugs to address autoimmune diseases, announced its official launch. Recent…
Read More...

Get ready for a revolutionary moment in the world of cell therapy as biotech trailblazers, big pharma, and immunology experts from around the globe gather at the 2nd Cell Therapy for…
Read More...

Epsilogen, a global leader in the development of immunoglobulin E (IgE) antibodies to treat cancer, announces the completion of a £12.5 million Series B expansion financing bringing the…
Read More...